A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA)

Publication | Closed Access

DOI

108

Citations

References

2006

Year

Rajiv Tandon, Ronald N. Marcus, Elyse Stock, Linda C. Riera, Dušan Kostić, Miranda Pans, Robert D. McQuade, Margaretta Nyilas, Taro Iwamoto, David Crandall

Schizophrenia Research

PsychiatryPsychotic DisorderMedicinePsychopharmacologySchizophreniaSocial SciencesPharmacotherapyMental HealthGeneral Psychiatric PracticeOpen-label StudyPharmacologyPsychopathologyBroad Effectiveness Trial